204 related articles for article (PubMed ID: 11418359)
1. Human papillomavirus infection, risk for subsequent development of cervical neoplasia and associated population attributable fraction.
Lehtinen M; Luukkaala T; Wallin KL; Paavonen J; Thoresen S; Dillner J; Hakama M
J Clin Virol; 2001 Aug; 22(1):117-24. PubMed ID: 11418359
[TBL] [Abstract][Full Text] [Related]
2. Seroresponses to human papillomavirus types 16, 18, 31, 33, and 45 virus-like particles in South African women with cervical cancer and cervical intraepithelial neoplasia.
Marais DJ; Rose RC; Lane C; Kay P; Nevin J; Denny L; Soeters R; Dehaeck CM; Williamson AL
J Med Virol; 2000 Apr; 60(4):403-10. PubMed ID: 10686023
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of specific types of human papillomavirus and cervical squamous intraepithelial lesions in consecutive, previously unscreened, West-African women over 35 years of age.
Xi LF; Touré P; Critchlow CW; Hawes SE; Dembele B; Sow PS; Kiviat NB
Int J Cancer; 2003 Mar; 103(6):803-9. PubMed ID: 12516102
[TBL] [Abstract][Full Text] [Related]
4. Immunoglobulin G responses against human papillomavirus type 16 virus-like particles in a prospective nonintervention cohort study of women with cervical intraepithelial neoplasia.
de Gruijl TD; Bontkes HJ; Walboomers JM; Schiller JT; Stukart MJ; Groot BS; Chabaud MM; Remmink AJ; Verheijen RH; Helmerhorst TJ; Meijer CJ; Scheper RJ
J Natl Cancer Inst; 1997 May; 89(9):630-8. PubMed ID: 9150187
[TBL] [Abstract][Full Text] [Related]
5. Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence.
Kjær SK; Frederiksen K; Munk C; Iftner T
J Natl Cancer Inst; 2010 Oct; 102(19):1478-88. PubMed ID: 20841605
[TBL] [Abstract][Full Text] [Related]
6. Trends over time in the incidence of cervical neoplasia in comparison to trends over time in human papillomavirus infection.
Dillner J
J Clin Virol; 2000 Oct; 19(1-2):7-23. PubMed ID: 11091144
[TBL] [Abstract][Full Text] [Related]
7. Antibody responses to HPV16 virus-like particles in women with cervical intraepithelial neoplasia infected with a variant HPV16.
Ellis JR; Etherington I; Galloway D; Luesley D; Young LS
Lancet; 1997 Apr; 349(9058):1069-70. PubMed ID: 9107250
[No Abstract] [Full Text] [Related]
8. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia.
Schlecht NF; Kulaga S; Robitaille J; Ferreira S; Santos M; Miyamura RA; Duarte-Franco E; Rohan TE; Ferenczy A; Villa LL; Franco EL
JAMA; 2001 Dec; 286(24):3106-14. PubMed ID: 11754676
[TBL] [Abstract][Full Text] [Related]
9. Epidemiological study in Okinawa, Japan, of human papillomavirus infection of the uterine cervix.
Maehama T
Infect Dis Obstet Gynecol; 2005 Jun; 13(2):77-80. PubMed ID: 16011997
[TBL] [Abstract][Full Text] [Related]
10. Proliferative T-cell responses to human papillomavirus type 16 E5 are decreased amongst women with high-grade neoplasia.
Gill DK; Bible JM; Biswas C; Kell B; Best JM; Punchard NA; Cason J
J Gen Virol; 1998 Aug; 79 ( Pt 8)():1971-6. PubMed ID: 9714245
[TBL] [Abstract][Full Text] [Related]
11. Age distribution of antibodies to human papillomavirus in children, women with cervical intraepithelial neoplasia and blood donors from South Africa.
Marais D; Rose RC; Williamson AL
J Med Virol; 1997 Feb; 51(2):126-31. PubMed ID: 9021543
[TBL] [Abstract][Full Text] [Related]
12. Type-specific HPV prevalence in invasive cervical cancer in the UK prior to national HPV immunisation programme: baseline for monitoring the effects of immunisation.
Mesher D; Cuschieri K; Hibbitts S; Jamison J; Sargent A; Pollock KG; Powell N; Wilson R; McCall F; Fiander A; Soldan K
J Clin Pathol; 2015 Feb; 68(2):135-40. PubMed ID: 25410654
[TBL] [Abstract][Full Text] [Related]
13. Frequency of HPV infection and GSH levels in plasma of women with cervical dysplasia.
Kwaśniewska A; Tukendorf A; Semczuk M
Eur J Gynaecol Oncol; 1997; 18(3):196-9. PubMed ID: 9174835
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus types in cervical dysplasia among young HPV-vaccinated women: Population-based nested case-control study.
Kann H; Hortlund M; Eklund C; Dillner J; Faust H
Int J Cancer; 2020 May; 146(9):2539-2546. PubMed ID: 31868230
[TBL] [Abstract][Full Text] [Related]
15. A prospective study of the relationship between prediagnostic human papillomavirus seropositivity and HPV DNA in subsequent cervical carcinomas.
Sigstad E; Lie AK; Luostarinen T; Dillner J; Jellum E; Lehtinen M; Thoresen S; Abeler V
Br J Cancer; 2002 Jul; 87(2):175-80. PubMed ID: 12107839
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus 16/18 seroprevalence in unvaccinated women over 30 years with normal cytology and with high grade cervical abnormalities in Australia: results from an observational study.
Velentzis LS; Sitas F; O'Connell DL; Darlington-Brown J; Egger S; Sinha R; Banks E; Frazer IH; Canfell K
BMC Infect Dis; 2014 Dec; 14():3861. PubMed ID: 25528152
[TBL] [Abstract][Full Text] [Related]
17. IgG antibodies to human papillomavirus 16, 52, 58, and 6 L1 capsids: case-control study of cervical intraepithelial neoplasia in Japan.
Matsumoto K; Yoshikawa H; Yasugi T; Nakagawa S; Kawana K; Takeoka A; Yaegashi N; Iwasaka T; Kanazawa K; Taketani Y; Kanda T
J Med Virol; 2003 Mar; 69(3):441-6. PubMed ID: 12526056
[TBL] [Abstract][Full Text] [Related]
18. Lymphoproliferative responses to human papillomavirus (HPV) type 16 proteins E6 and E7: outcome of HPV infection and associated neoplasia.
Kadish AS; Ho GY; Burk RD; Wang Y; Romney SL; Ledwidge R; Angeletti RH
J Natl Cancer Inst; 1997 Sep; 89(17):1285-93. PubMed ID: 9293919
[TBL] [Abstract][Full Text] [Related]
19. Increased risk of cervical disease among human immunodeficiency virus-infected women with severe immunosuppression and high human papillomavirus load(1).
Heard I; Tassie JM; Schmitz V; Mandelbrot L; Kazatchkine MD; Orth G
Obstet Gynecol; 2000 Sep; 96(3):403-9. PubMed ID: 10960634
[TBL] [Abstract][Full Text] [Related]
20. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica.
Herrero R; Hildesheim A; Bratti C; Sherman ME; Hutchinson M; Morales J; Balmaceda I; Greenberg MD; Alfaro M; Burk RD; Wacholder S; Plummer M; Schiffman M
J Natl Cancer Inst; 2000 Mar; 92(6):464-74. PubMed ID: 10716964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
